Geode Capital Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

Shares

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$13.06 - $15.0 $157,621 - $181,035	12,069 Added 4.64%	272,015 $4.02 Million
Q4 2023 Feb 13, 2024	BUY	$12.02 - $13.41 $100,499 - $112,121	8,361 Added 3.32%	259,946 $3.49 Million
Q3 2023 Nov 13, 2023	BUY	$11.6 - $12.52 $90,282 - $97,443	7,783 Added 3.19%	251,585 $3.1 Million
Q2 2023 Aug 11, 2023	BUY	$12.02 - $13.07 $1.37 Million - $1.49 Million	113,638 Added 87.3%	243,802 $3 Million
Q1 2023 May 15, 2023	SELL	$11.35 - $12.32 $46,103 - $50,043	-4,062 Reduced 3.03%	130,164 $1.6 Million
Q4 2022 Feb 13, 2023	BUY	$3.68 - $12.51 $122,978 - $418,059	33,418 Added 33.15%	134,226 $1.54 Million
Q2 2022 Aug 12, 2022	BUY	$4.89 - $7.13 $5,603 - $8,170	1,146 Added 1.15%	100,808 $599,000
Q1 2022 May 13, 2022	BUY	$3.75 - $6.82 $11,137 - $20,255	2,970 Added 3.07%	99,662 $630,000
Q2 2021 Aug 13, 2021	BUY	$6.04 - $7.77 $33,123 - $42,610	5,484 Added 6.01%	96,692 $617,000
Q1 2021 May 12, 2021	BUY	$6.15 - $8.7 $47,502 - $67,198	7,724 Added 9.25%	91,208 $572,000
Q3 2020 Nov 13, 2020	BUY	$3.1 - $4.3 $7,244 - $10,049	2,337 Added 2.88%	83,484 $333,000
Q4 2019 Feb 13, 2020	BUY	$3.15 - $4.67 $784 - $1,162	249 Added 0.31%	81,147 $255,000
Q1 2019 May 14, 2019	SELL	$3.19 - $5.73 $9,215 - $16,553	-2,889 Reduced 3.45%	80,898 $562,000
Q4 2018 Feb 13, 2019	BUY	$2.95 - $4.15 $1,693 - $2,382	574 Added 0.69%	83,787 $323,000
Q3 2018 Nov 13, 2018	BUY	$3.91 - $4.66 $3,409 - $4,063	872 Added 1.06%	83,213 $443,000
Q2 2018 Aug 14, 2018	SELL	$3.86 - $7.61 $106,296 - $209,564	-27,538 Reduced 25.06%	82,341 $404,000
Q1 2018 May 15, 2018	BUY	$6.24 - $9.15 $7,849 - $11,510	1,258 Added 1.16%	109,879 $884,000
Q4 2017 Feb 13, 2018	BUY	$7.99 - $11.87 $41,228 - $61,249	5,160 Added 4.99%	108,621 $1.11 Million
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $944,598 - $1.21 Million	103,461	103,461 $1.5 Million

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.